DarioHealth Reports Q1 2025 Financials, Equity Issuances
Ticker: DRIO · Form: 10-Q · Filed: May 14, 2025 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, equity-issuance
TL;DR
DarioHealth's Q1 2025: Assets $42.7M, Liabilities $38.4M. Closed Series C & D equity rounds.
AI Summary
DarioHealth Corp. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $42.7 million and total liabilities of $38.4 million. Key events during the period included Series D purchase agreements on January 7, 2025, and Series C purchase agreements in February 2025, involving preferred stock issuances.
Why It Matters
This filing provides insight into DarioHealth's financial position and recent capital-raising activities, which are crucial for understanding its operational capacity and future growth prospects.
Risk Assessment
Risk Level: medium — The company's financial figures and recent equity issuances suggest ongoing financial activity and potential reliance on capital markets, which carries inherent risks.
Key Numbers
- $42.7M — Total Assets (As of March 31, 2025)
- $38.4M — Total Liabilities (As of March 31, 2025)
Key Players & Entities
- DarioHealth Corp. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- $42.7 million (dollar_amount) — Total assets
- $38.4 million (dollar_amount) — Total liabilities
- 2025-01-07 (date) — Series D purchase agreement date
- 2025-02-01 (date) — Series C purchase agreement start date
FAQ
What were DarioHealth's total assets and liabilities as of March 31, 2025?
As of March 31, 2025, DarioHealth reported total assets of $42,706,594 and total liabilities of $38,388,431.
When did DarioHealth enter into Series D purchase agreements?
DarioHealth entered into Series D purchase agreements on January 7, 2025.
What type of preferred stock was involved in the Series C purchase agreements?
The Series C purchase agreements involved Series C1 Preferred Stock.
What was the previous name of DarioHealth Corp.?
The former company name was LabStyle Innovations Corp., with a date of name change on November 1, 2011.
What is DarioHealth Corp.'s Standard Industrial Classification code?
DarioHealth Corp.'s Standard Industrial Classification code is 3841, for Surgical & Medical Instruments & Apparatus.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding DarioHealth Corp. (DRIO).